Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01834651
Title A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral Metastases
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Edwin Posadas, MD
Indications

prostate cancer

Therapies

Cabozantinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.